Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE7A | Q13946 | 1/20 | 0.31 |
| ▸ | PDE7B | Q9NP56 | 1/20 | 0.31 |
| ▸ | CRBN | Q96SW2 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL630051 | 0.69 | — | — | |
| SCHEMBL847134 | 0.67 | — | — | |
| SCHEMBL6322598 | 0.67 | — | — | |
| SCHEMBL2081975 | 0.65 | PDE7A (0.44) | PDE7APDE7B | |
| SCHEMBL4420485 | 0.65 | — | — | |
| SCHEMBL121542 | 0.62 | — | — | |
| Hydrochloric Acid SCHEMBL10924919 | 0.62 | — | — | |
| SCHEMBL10919946 | 0.62 | CA12 (0.37) | PDE7APDE7B | |
| SCHEMBL11223642 | 0.58 | CRBN (0.42) | CRBN | |
| SCHEMBL577777 | 0.58 | CRBN (0.42) | CRBN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9381140-B2 | Radically polymerisable dental material, cured product and usage | KETTENBACH GMBH & CO. KG (DE) | 2016-07-05 | — | — | US | claimed |
| US-20150231041-A1 | Radically Polymerisable Dental Material, Cured Product and Usage | KETTENBACH GMBH & CO. KG (DE) | 2015-08-20 | — | — | US | claimed |
| US-6852775-B1 | Polymerizable dental compositions | 3M ESPE AG (DE) | 2005-02-08 | — | — | US | claimed |
| EP-0059451-B1 | 1,2,6-THIADIAZINE-3,5-DIONE-1,1 DIOXIDES AND THEIR USE | ESPE Fabrik Pharmazeutischer Präparate GmbH (DE) | 1985-07-31 | — | — | EP | claimed |
| EP-0059451-A1 | 1,2,6-Thiadiazine-3,5-dione-1,1 dioxides and their use | ESPE Fabrik Pharmazeutischer Präparate GmbH (DE) | 1982-09-08 | — | — | EP | claimed |
| JP-4218503-A | — | — | None | — | — | JP | disclosed |
| EP-4377367-A1 | COMPOSITION INCLUDING MONOMER WITH A CARBOXYLIC ACID GROUP, MONOMER WITH A HYDROXYL GROUP, AN ALKYL MONOMER, AND CROSSLINKER AND RELATED ARTICLE AND METHOD | 3M Innovative Properties Company (US) | 2024-06-05 | — | — | EP | disclosed |
| US-11998417-B2 | Process for producing a surface-modified dental article | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2024-06-04 | — | — | US | disclosed |
| US-20240084060-A1 | COMPOSITION INCLUDING AN ACRYLIC MONOMER WITH A CARBOXYLIC ACID GROUP, AN ACRYLIC MONOMER WITH A HYDROXYL GROUP, AN ALKYL (METH)ACRYLATE MONOMER AND CROSSLINKER, AND RELATED ARTICLES AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY | 2024-03-14 | — | — | US | disclosed |
| US-20240076523-A1 | FREE-RADICALLY POLYMERIZABLE CROSSLINKER, CURABLE COMPOSITION, AND ADHESIVE THEREFROM | 3M INNOVATIVE PROPERTIES COMPANY | 2024-03-07 | — | — | US | disclosed |
| US-20240059940-A1 | COMPOSITION INCLUDING MONOMER WITH A CARBOXYLIC ACID GROUP, MONOMER WITH A HYDROXYL GROUP, A CYCLOALKYL MONOMER, AND CROSSLINKER AND RELATED ARTICLES AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY | 2024-02-22 | — | — | US | disclosed |
| US-20230399463-A1 | FREE-RADICALLY POLYMERIZABLE CROSSLINKER, CURABLE COMPOSITION, AND ADHESIVE THEREFROM | 3M INNOVATIVE PROPERTIES COMPANY | 2023-12-14 | — | — | US | disclosed |
| EP-0059451-B1 | 1,2,6-THIADIAZINE-3,5-DIONE-1,1 DIOXIDES AND THEIR USE | ESPE Fabrik Pharmazeutischer Präparate GmbH (DE) | 1985-07-31 | — | — | EP | disclosed |
| EP-0059451-B1 | 1,2,6-THIADIAZINE-3,5-DIONE-1,1 DIOXIDES AND THEIR USE | ESPE Fabrik Pharmazeutischer Präparate GmbH (DE) | 1985-07-31 | — | — | EP | disclosed |
| US-4443587-A | FOR ADDITION POLYMERS | ABITZ, MORF, GRITSCHNEDER (DE) | 1984-04-17 | — | — | US | disclosed |
| US-4443587-A | FOR ADDITION POLYMERS | ABITZ, MORF, GRITSCHNEDER (DE) | 1984-04-17 | — | — | US | disclosed |
| US-4443587-A | FOR ADDITION POLYMERS | ABITZ, MORF, GRITSCHNEDER (DE) | 1984-04-17 | — | — | US | disclosed |
| EP-0059451-A1 | 1,2,6-Thiadiazine-3,5-dione-1,1 dioxides and their use | ESPE Fabrik Pharmazeutischer Präparate GmbH (DE) | 1982-09-08 | — | — | EP | disclosed |
| EP-0059451-A1 | 1,2,6-Thiadiazine-3,5-dione-1,1 dioxides and their use | ESPE Fabrik Pharmazeutischer Präparate GmbH (DE) | 1982-09-08 | — | — | EP | disclosed |
| EP-0059451-A1 | 1,2,6-Thiadiazine-3,5-dione-1,1 dioxides and their use | ESPE Fabrik Pharmazeutischer Präparate GmbH (DE) | 1982-09-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150231041-A1 | Radically Polymerisable Dental Material, Cured Product and Usage | MMAB, MTCL3, TUBB4B | PDE7A 2433/4885PDE7B 3170/4885CRBN 16/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.